Iris L. K. Wong

1.7k total citations
48 papers, 1.3k citations indexed

About

Iris L. K. Wong is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Iris L. K. Wong has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 18 papers in Molecular Biology and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Iris L. K. Wong's work include Drug Transport and Resistance Mechanisms (22 papers), Research on Leishmaniasis Studies (12 papers) and HIV/AIDS drug development and treatment (8 papers). Iris L. K. Wong is often cited by papers focused on Drug Transport and Resistance Mechanisms (22 papers), Research on Leishmaniasis Studies (12 papers) and HIV/AIDS drug development and treatment (8 papers). Iris L. K. Wong collaborates with scholars based in Hong Kong, China and Canada. Iris L. K. Wong's co-authors include Larry M. C. Chow, Tak Hang Chan, Kin‐Fai Chan, Yunzhe Zhao, Tao Jiang, Brendan A. Burkett, Manku Rana, Sabrina S. M. Lee, James M. Wakeling and Ollie M. Blake and has published in prestigious journals such as Biomaterials, Cancer Research and Chemical Communications.

In The Last Decade

Iris L. K. Wong

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris L. K. Wong Hong Kong 23 509 448 276 184 176 48 1.3k
Jawahar Lal India 21 402 0.8× 156 0.3× 400 1.4× 100 0.5× 193 1.1× 83 1.5k
Jonathan Cheong United States 13 444 0.9× 412 0.9× 140 0.5× 161 0.9× 39 0.2× 30 1.3k
Yingke He Singapore 13 450 0.9× 138 0.3× 143 0.5× 144 0.8× 367 2.1× 23 1.3k
Ruchika Sharma India 23 660 1.3× 275 0.6× 124 0.4× 96 0.5× 36 0.2× 83 1.4k
Keith Hoffmaster United States 16 298 0.6× 625 1.4× 57 0.2× 154 0.8× 100 0.6× 20 1.4k
Yongmei Li China 18 316 0.6× 214 0.5× 55 0.2× 86 0.5× 88 0.5× 34 1.1k
Rosa I. Sánchez United States 22 498 1.0× 105 0.2× 127 0.5× 458 2.5× 58 0.3× 50 1.4k
Rupashree Sen India 19 472 0.9× 260 0.6× 125 0.5× 85 0.5× 431 2.4× 33 1.5k
Dejan Baskić Serbia 19 489 1.0× 406 0.9× 319 1.2× 87 0.5× 33 0.2× 96 1.4k

Countries citing papers authored by Iris L. K. Wong

Since Specialization
Citations

This map shows the geographic impact of Iris L. K. Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris L. K. Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris L. K. Wong more than expected).

Fields of papers citing papers by Iris L. K. Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris L. K. Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris L. K. Wong. The network helps show where Iris L. K. Wong may publish in the future.

Co-authorship network of co-authors of Iris L. K. Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Iris L. K. Wong. A scholar is included among the top collaborators of Iris L. K. Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris L. K. Wong. Iris L. K. Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hopkins, Kristine, et al.. (2024). 10. Reproductive Autonomy: Supporting Contraceptive Agency for Young People in the Clinic Visit. Journal of Adolescent Health. 74(3). S6–S6.
2.
Surur, Abdrrahman Shemsu, Iris L. K. Wong, Lukas Schulig, et al.. (2024). Fexinidazole optimization: enhancing anti-leishmanial profile, metabolic stability and hERG safety. RSC Medicinal Chemistry. 15(11). 3837–3852.
3.
Wong, Iris L. K., Hkw Law, Xingkai Wang, et al.. (2023). In Vivo Reversal of P-Glycoprotein-Mediated Drug Resistance in a Breast Cancer Xenograft and in Leukemia Models Using a Novel, Potent, and Nontoxic Epicatechin EC31. International Journal of Molecular Sciences. 24(5). 4377–4377. 7 indexed citations
4.
Hassard, Juliet, Iris L. K. Wong, & Weiwei Wang. (2022). Workplace empowerment, psychological empowerment and work-related wellbeing in southeast Asian employees: a cross-sectional survey. Health Promotion International. 37(4). 11 indexed citations
5.
Wong, Iris L. K., et al.. (2022). Discovery of a Flavonoid FM04 as a Potent Inhibitor to Reverse P-Glycoprotein-Mediated Drug Resistance in Xenografts and Improve Oral Bioavailability of Paclitaxel. International Journal of Molecular Sciences. 23(23). 15299–15299. 10 indexed citations
6.
Wong, Iris L. K., et al.. (2021). Synthesis and evaluation of stereoisomers of methylated catechin and epigallocatechin derivatives on modulating P-glycoprotein-mediated multidrug resistance in cancers. European Journal of Medicinal Chemistry. 226. 113795–113795. 15 indexed citations
7.
Wong, Iris L. K., Kin‐Fai Chan, Zhen Liu, et al.. (2021). Flavonoid Monomers as Potent, Nontoxic, and Selective Modulators of the Breast Cancer Resistance Protein (ABCG2). Journal of Medicinal Chemistry. 64(19). 14311–14331. 11 indexed citations
8.
Li, Peng, Yunjiao He, Teng Chen, et al.. (2020). Disruption of SND1–MTDH Interaction by a High Affinity Peptide Results in SND1 Degradation and Cytotoxicity to Breast Cancer Cells In Vitro and In Vivo. Molecular Cancer Therapeutics. 20(1). 76–84. 13 indexed citations
9.
Wong, Iris L. K., et al.. (2019). Triazole Bridged Flavonoid Dimers as Potent, Nontoxic, and Highly Selective Breast Cancer Resistance Protein (BCRP/ABCG2) Inhibitors. Journal of Medicinal Chemistry. 62(18). 8578–8608. 34 indexed citations
10.
11.
Gao, Wei, Wenbin Jin, Ning Sun, et al.. (2018). Boosting the efficacy of anti-MRSA β-lactam antibiotics via an easily accessible, non-cytotoxic and orally bioavailable FtsZ inhibitor. European Journal of Medicinal Chemistry. 163. 95–115. 27 indexed citations
12.
Ashok, Penta, Subhash Chander, Larry M. C. Chow, et al.. (2016). Synthesis and in-vitro anti-leishmanial activity of (4-arylpiperazin-1-yl)(1-(thiophen-2-yl)-9 H -pyrido[3,4- b ]indol-3-yl)methanone derivatives. Bioorganic Chemistry. 70. 100–106. 22 indexed citations
13.
Wang, Zhen, Iris L. K. Wong, Zhen Liu, et al.. (2015). Optimization of permethyl ningalin B analogs as P-glycoprotein inhibitors. Bioorganic & Medicinal Chemistry. 23(17). 5566–5573. 14 indexed citations
14.
Wong, Iris L. K., et al.. (2014). Modification of Marine Natural Product Ningalin B and SAR Study Lead to Potent P-Glycoprotein Inhibitors. Marine Drugs. 12(10). 5209–5221. 13 indexed citations
15.
Jin, Wenbin, et al.. (2013). Structure–Activity Relationship Study of Permethyl Ningalin B Analogues as P-Glycoprotein Chemosensitizers. Journal of Medicinal Chemistry. 56(22). 9057–9070. 37 indexed citations
16.
Chan, Kin‐Fai, et al.. (2012). Amine Linked Flavonoid Dimers as Modulators for P-Glycoprotein-Based Multidrug Resistance: Structure–Activity Relationship and Mechanism of Modulation. Journal of Medicinal Chemistry. 55(5). 1999–2014. 68 indexed citations
17.
Yuan, Jian‐Min, et al.. (2012). Synthesis of methylated quercetin derivatives and their reversal activities on P-gp- and BCRP-mediated multidrug resistance tumour cells. European Journal of Medicinal Chemistry. 54. 413–422. 61 indexed citations
18.
Wong, Iris L. K., et al.. (2009). Modulation of Multidrug Resistance Protein 1 (MRP1/ABCC1)-Mediated Multidrug Resistance by Bivalent Apigenin Homodimers and Their Derivatives. Journal of Medicinal Chemistry. 52(17). 5311–5322. 77 indexed citations
19.
Wong, Iris L. K., Kin‐Fai Chan, Yanxiang Zhao, Tak Hang Chan, & Larry M. C. Chow. (2009). Quinacrine and a novel apigenin dimer can synergistically increase the pentamidine susceptibility of the protozoan parasite Leishmania. Journal of Antimicrobial Chemotherapy. 63(6). 1179–1190. 24 indexed citations
20.
Chow, Larry M. C., Johnny Tang, Chung Chui, et al.. (2002). Antiproliferative Activity of the Extract of <i>Gleditsia sinensis</i> Fruit on Human Solid Tumour Cell Lines. Chemotherapy. 48(6). 303–308. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jawahar Lal Breakdown of academic impact, for papers by Jonathan Cheong Breakdown of academic impact, for papers by Yingke He Breakdown of academic impact, for papers by Ruchika Sharma Breakdown of academic impact, for papers by Keith Hoffmaster Breakdown of academic impact, for papers by Yongmei Li Breakdown of academic impact, for papers by Rosa I. Sánchez Breakdown of academic impact, for papers by Rupashree Sen Breakdown of academic impact, for papers by Dejan Baskić
Rankless by CCL
2026